Testicular Yolk Sac Tumor

specific

A non-seminomatous malignant germ cell tumor arising from the testis. It affects infants, young children, and postpubertal males. It is the most frequently seen testicular neoplasm during childhood. The vast majority of patients present with an asymptomatic scrotal mass. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). It metastasizes to distant anatomic sites. Prognostic factors relate to the clinical stage and the degree of AFP elevation.

Centers

Active Trials

—

Cancer Funding

Top Centers for Testicular Yolk Sac Tumor(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	51.5
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive	—	—	51.5
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.5
4	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive	—	—	51.5
5	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	—	—	51.5
6	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive	—	—	51.5
7	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	51.5
8	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	51.5
9	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	51.5
10	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive	—	—	51.5
11	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.5
12	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.5
13	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	—	51.5
14	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	51.5
15	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	51.5
16	Cedars-Sinai CancerLos Angeles, CA	—	—	51.5
17	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.5
18	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	—	51.5
19	University of Illinois Cancer CenterChicago, IL	—	—	51.5
20	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	—	51.5
21	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	—	51.5
22	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.5
23	Boston University Cancer CenterBoston, MA	—	—	51.5
24	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	51.5
25	Cancer Center at IllinoisUrbana, IL	—	—	51.5
26	Penn State Cancer InstituteHershey, PA	—	—	51.5
27	University of Cincinnati Cancer CenterCincinnati, OH	—	—	51.5
28	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR	—	—	51.5
29	Upstate Cancer CenterSyracuse, NY	—	—	51.5
30	BC CancerVancouver, BC	—	—	51.5
31	Tampa General Hospital Cancer InstituteTampa, FL	—	—	51.5
32	Princess Margaret Cancer CentreToronto, ON	—	—	51.5
33	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →